CAR T-Cell therapy targets hidden leukemia cells after chemotherapy
NCT ID NCT06144606
Summary
This study is testing whether KTE-X19, a type of CAR T-cell therapy, can help adults with B-cell acute lymphoblastic leukemia who are in remission but still have tiny amounts of cancer cells detectable in their bone marrow. The treatment involves collecting and genetically modifying a patient's own immune cells to better recognize and attack leukemia cells. Researchers will measure how long patients stay cancer-free and monitor for side effects like cytokine release syndrome.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE LYMPHOBLASTIC LEUKEMIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Moffitt Cancer Center
RECRUITINGTampa, Florida, 33612, United States
Contact
Contact
Contact
Contact
Conditions
Explore the condition pages connected to this study.